Cravatex Limited has announced its unaudited financial results for the third quarter of FY26 ended December 31, 2025, demonstrating strong operational performance across both standalone and consolidated metrics. The Board of Directors approved these results during their meeting held on February 12, 2026.

Standalone Financial Performance

The company's standalone operations showed impressive growth during Q3FY26. Revenue from operations increased significantly by 23.40% to ₹313.12 lacs compared to ₹253.76 lacs in the corresponding quarter of the previous year.

The company's total expenses for Q3FY26 stood at ₹406.12 lacs compared to ₹352.02 lacs in Q3FY25. Purchase of stock-in-trade remained the largest expense component at ₹310.04 lacs, followed by employee benefits expense at ₹41.10 lacs.

Nine-Month Performance Analysis

For the nine months ended December 31, 2025, Cravatex reported standalone revenue from operations of ₹709.84 lacs compared to ₹479.59 lacs in the corresponding period of FY25, representing a growth of 48.02%. The net profit for the nine-month period was ₹341.25 lacs compared to ₹484.54 lacs in the previous year.

Consolidated Results

On a consolidated basis, the company's performance was equally robust. Revenue from operations for Q3FY26 reached ₹3,678.92 lacs compared to ₹3,243.07 lacs in Q3FY25, marking a growth of 13.44%.

The consolidated results include contributions from the company's subsidiaries BB (UK) Limited and BB Euro GmbH. For the nine months ended December 31, 2025, consolidated revenue from operations was ₹11,136.13 lacs compared to ₹11,324.29 lacs in the corresponding period of FY25.

Operational Highlights

The company operates in a single primary business segment and maintains its focus on operational efficiency. Employee benefits expense on a consolidated basis increased to ₹758.83 lacs in Q3FY26 from ₹637.25 lacs in Q3FY25, reflecting the company's investment in human resources.

Depreciation and amortisation expense on a consolidated basis was ₹37.63 lacs for Q3FY26 compared to ₹39.69 lacs in the previous year quarter. Finance costs remained controlled at ₹8.69 lacs for the quarter.

Regulatory Compliance

The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) and have undergone limited review by the statutory auditors GPS & Associates. The results comply with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Cravatex Limited , a diversified company, has announced its unaudited financial results for the first quarter, revealing a mixed performance across its standalone and consolidated operations.

Standalone Performance

On a standalone basis, Cravatex Limited demonstrated a positive financial outcome for Q1:

• Revenue from operations stood at Rs. 144.14 lakhs
• Total income reached Rs. 279.48 lakhs
• The company reported a profit of Rs. 44.21 lakhs
• Basic earnings per share (EPS) was Rs. 1.71

Consolidated Results

The consolidated financial picture, however, presented some challenges:

• Consolidated revenue from operations was Rs. 2,312.69 lakhs
• Total income amounted to Rs. 2,833.65 lakhs
• The group recorded a net loss of Rs. 136.77 lakhs

Subsidiary Performance

The consolidated results include the performance of Cravatex's subsidiaries:

• BB (UK) Limited and BB Euro GmbH contributed a total income of Rs. 2,554.16 lakhs
• These subsidiaries reported a combined net loss of Rs. 180.99 lakhs

Financial Highlights

Management Commentary

Rajesh Batra, Chairman and Managing Director of Cravatex Limited, approved the financial results along with the Board of Directors. The company's management and auditors have conducted a thorough review of both standalone and consolidated results.

Audit Review

GPS & Associates, the statutory auditors, have carried out a limited review of the financial results for the quarter, in accordance with the regulatory requirements.

Segment Information

Cravatex Limited continues to operate in a single primary business segment, as noted in the financial statement.

The financial results were reviewed by the Audit Committee and approved by the Board of Directors. The company has prepared the statement in accordance with the Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013, and other recognized accounting practices and policies.

Investors and stakeholders should note that while the standalone entity has shown profitability, the consolidated results reflect the challenges faced by the group's international operations.